Covidien Ltd., which had been locked in patent litigation over diagnostic devices with Medrad Inc. of Warrendale, Penn., said the companies reached a settlement Jan. 18, according to a filing with the Securities and Exchange Commission today. Under the agreement, the Mansfield-based health-products maker agreed to pay Medrad $17 million. Both companies also dropped their legal claims against the other. SOURCE: Boston.com

News from our sister sites